Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33


Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DP.

Diagn Microbiol Infect Dis. 2019 Nov;95(3):114861. doi: 10.1016/j.diagmicrobio.2019.06.013. Epub 2019 Jul 5.


Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.

Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP.

J Antimicrob Chemother. 2019 Jul 1;74(7):1904-1910. doi: 10.1093/jac/dkz100.


Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module.

Wurster S, Kumaresan PR, Albert ND, Hauser PJ, Lewis RE, Kontoyiannis DP.

mBio. 2019 May 28;10(3). pii: e00673-19. doi: 10.1128/mBio.00673-19.


A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies.

Tatara AM, Watson E, Albert ND, Kontoyiannis PD, Kontoyiannis DP, Mikos AG.

J Biomed Mater Res A. 2019 Sep;107(9):1867-1874. doi: 10.1002/jbm.a.36671. Epub 2019 Apr 7.


Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Wurster S, Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01896-18. doi: 10.1128/AAC.01896-18. Print 2019 Feb.


Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.


Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Tatara AM, Rozich AJ, Kontoyiannis PD, Watson E, Albert ND, Bennett GN, Mikos AG.

J Mater Sci Mater Med. 2018 May 11;29(5):70. doi: 10.1007/s10856-018-6073-1.


Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP.

Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.


Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin.

Lionakis MS, Albert ND, Swamydas M, Lee CR, Loetscher P, Kontoyiannis DP.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02365-16. doi: 10.1128/AAC.02365-16. Print 2017 Mar.


Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.

Bellanger AP, Tatara AM, Shirazi F, Gebremariam T, Albert ND, Lewis RE, Ibrahim AS, Kontoyiannis DP.

J Infect Dis. 2016 Jul 1;214(1):114-21. doi: 10.1093/infdis/jiw090. Epub 2016 Mar 16.


Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.

Bellanger AP, Albert ND, Lewis RE, Walsh TJ, Kontoyiannis DP.

Antimicrob Agents Chemother. 2015 Dec;59(12):7830-2. doi: 10.1128/AAC.01583-15. Epub 2015 Sep 21.


Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.

Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2014 Nov;58(11):6767-72. doi: 10.1128/AAC.03569-14. Epub 2014 Sep 2.


Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.

Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, Roszik J, Rabinovich B, Olivares S, Krishnamurthy J, Zhang L, Najjar AM, Huls MH, Lee DA, Champlin RE, Kontoyiannis DP, Cooper LJ.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10660-5. doi: 10.1073/pnas.1312789111. Epub 2014 Jul 7.


Methylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies.

Farmakiotis D, Shirazi F, Zhao Y, Saad PJ, Albert ND, Roilides E, Walsh TJ, Perlin DS, Kontoyiannis DP.

J Infect Dis. 2014 Nov 1;210(9):1471-5. doi: 10.1093/infdis/jiu289. Epub 2014 May 15.


Aspergillus fumigatus hyphal damage caused by noninvasive radiofrequency field-induced hyperthermia.

Kaluarachchi WD, Cisneros BT, Corr SJ, Albert ND, Curley SA, Kontoyiannis DP.

Antimicrob Agents Chemother. 2013 Sep;57(9):4444-8. doi: 10.1128/AAC.01017-13. Epub 2013 Jul 8.


Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.

Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CA.

J Infect Dis. 2013 Jul;208(1):83-91. doi: 10.1093/infdis/jit138. Epub 2013 Apr 1.


Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.

Ben-Ami R, Albert ND, Lewis RE, Kontoyiannis DP.

J Infect Dis. 2013 Apr;207(7):1066-74. doi: 10.1093/infdis/jis940. Epub 2013 Jan 9.


Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment.

Ben-Ami R, Watson CC, Lewis RE, Albert ND, Arias CA, Raad II, Kontoyiannis DP.

Microb Pathog. 2013 Feb;55:16-20. doi: 10.1016/j.micpath.2012.11.012. Epub 2012 Dec 8.


Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia.

Kontoyiannis DP, Georgiadou SP, Wierda WG, Wright S, Albert ND, Ferrajoli A, Keating M, Lewis RE.

Leuk Lymphoma. 2013 Aug;54(8):1730-3. doi: 10.3109/10428194.2012.750723. Epub 2013 Feb 20.


Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.

Lewis RE, Albert ND, Liao G, Hou J, Prince RA, Kontoyiannis DP.

Antimicrob Agents Chemother. 2010 Mar;54(3):1298-304. doi: 10.1128/AAC.01222-09. Epub 2009 Dec 28.


Gamma scintigraphy imaging of murine invasive pulmonary aspergillosis with a (111)In-labeled cyclic peptide.

Yang Z, Kontoyiannis DP, Wen X, Xiong C, Zhang R, Albert ND, Li C.

Nucl Med Biol. 2009 Apr;36(3):259-66. doi: 10.1016/j.nucmedbio.2008.12.004.


Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.

Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2008 Nov;52(11):4178-80. doi: 10.1128/AAC.00715-08. Epub 2008 Aug 25.


Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis.

Lewis RE, Albert ND, Kontoyiannis DP.

J Antimicrob Chemother. 2008 May;61(5):1140-4. doi: 10.1093/jac/dkn069. Epub 2008 Feb 27.


Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.

Chamilos G, Lewis RE, Lamaris GA, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2008 Apr;52(4):1325-9. doi: 10.1128/AAC.01393-07. Epub 2008 Jan 22.


Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.

Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N.

Antimicrob Agents Chemother. 2008 Feb;52(2):735-8. Epub 2007 Dec 10.


Increased culture recovery of Zygomycetes under physiologic temperature conditions.

Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJ.

Am J Clin Pathol. 2007 Feb;127(2):208-12.


Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.

Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP.

J Infect Dis. 2006 Apr 1;193(7):1014-22. Epub 2006 Feb 28. Erratum in: J Infect Dis. 2006 Nov 1;194(9):1342.


Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.

Lionakis MS, Lahdenranta J, Sun J, Liu W, Lewis RE, Albert ND, Pasqualini R, Arap W, Kontoyiannis DP.

Infect Immun. 2005 Nov;73(11):7747-58.


Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.

Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP.

Diagn Microbiol Infect Dis. 2005 May;52(1):15-20.


Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.

Lionakis MS, Lewis RE, May GS, Wiederhold NP, Albert ND, Halder G, Kontoyiannis DP.

J Infect Dis. 2005 Apr 1;191(7):1188-95. Epub 2005 Feb 28.


Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.

Kontoyiannis DP, Lewis RE, Lionakis MS, Albert ND, May GS, Raad II.

Diagn Microbiol Infect Dis. 2003 Oct;47(2):415-9.


Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.

Kontoyiannis DP, Lewis RE, Osherov N, Albert ND, May GS.

J Antimicrob Chemother. 2003 Feb;51(2):313-6.


Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae.

Osherov N, May GS, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2002 Aug;46(8):2462-9.

Supplemental Content

Loading ...
Support Center